235 related articles for article (PubMed ID: 32567984)
1. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
Gamea MM; Kamal DA; Donia AA; Hegab DS
J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
4. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
Badran AY; Ali AU; Gomaa AS
Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
[TBL] [Abstract][Full Text] [Related]
6. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
7. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
8. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
9. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
Malik F; Hanif MM; Mustafa G
J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
[TBL] [Abstract][Full Text] [Related]
10. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
Tekam PS; Belgaumkar VA
Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
[TBL] [Abstract][Full Text] [Related]
11. Platelet-Rich Plasma in Melasma-A Systematic Review.
Sarkar R; Gupta M
Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
[TBL] [Abstract][Full Text] [Related]
12. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single-blind randomized clinical trial.
Shamsi Meymandi S; Mozayyeni A; Shamsi Meymandi M; Aflatoonian M
J Cosmet Dermatol; 2020 Nov; 19(11):2906-2911. PubMed ID: 32406162
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
Polat Y; Saraç G
Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
[TBL] [Abstract][Full Text] [Related]
15. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
16. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
17. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
Wang Y; Tang L; Duan J; Wang L; Ye F
Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
